Literature DB >> 3456150

Promoter and enhancer activities of long terminal repeats associated with cellular retrovirus-like (VL30) elements.

G Rotman, A Itin, E Keshet.   

Abstract

LTR units associated with cellular retrovirus-like elements are abundantly present in chromosomal DNA of animal cells. We have analyzed the promoter and enhancer activities of diverse LTR units associated with different members of the murine retrovirus-like family known as VL30. We report here that the structurally heterogenous VL30 LTRs displayed highly variable promoter/enhancer activities. The most active VL30 LTR (designated VL3) promoted CAT activity to levels six-fold higher than the LTR of the strongly transforming retrovirus, MSV. This VL30 transcription unit, containing a unique U3 region, was further characterized by S1 nuclease mapping. VL3 LTR functioned as an enhancer in CAT constructs containing a SV40 promoter. In addition, a defined U3 segment was shown to augment expression of CAT in an orientation independent manner. VL3 LTR also served as an efficient promoter and enhancer in heterologous monkey cells. These results suggest that certain resident LTRs possess promoter and enhancer capacities greater than those possessed by LTRs of infectious retroviruses.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3456150      PMCID: PMC339455          DOI: 10.1093/nar/14.2.645

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  21 in total

1.  Heterogeneity of "virus-like" genes encoding retrovirus-associated 30S RNA and their organization within the mouse genome.

Authors:  E Keshet; Y Shaul; J Kaminchik; H Aviv
Journal:  Cell       Date:  1980-06       Impact factor: 41.582

2.  The long terminal repeat of an endogenous intracisternal A-particle gene functions as a promoter when introduced into eucaryotic cells by transfection.

Authors:  K K Lueders; J W Fewell; E L Kuff; T Koch
Journal:  Mol Cell Biol       Date:  1984-10       Impact factor: 4.272

3.  SV40-transformed simian cells support the replication of early SV40 mutants.

Authors:  Y Gluzman
Journal:  Cell       Date:  1981-01       Impact factor: 41.582

4.  Host-specific activation of transcription by tandem repeats from simian virus 40 and Moloney murine sarcoma virus.

Authors:  L A Laimins; G Khoury; C Gorman; B Howard; P Gruss
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

5.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

6.  Sequences associated with intracisternal A particles are reiterated in the mouse genome.

Authors:  K K Lueders; E L Kuff
Journal:  Cell       Date:  1977-12       Impact factor: 41.582

7.  Patterns of genomic distribution and sequence heterogeneity of a murine "retrovirus-like" multigene family.

Authors:  E Keshet; A Itin
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

8.  Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus.

Authors:  E H Chang; M E Furth; E M Scolnick; D R Lowy
Journal:  Nature       Date:  1982-06-10       Impact factor: 49.962

9.  Some structural and antigenic properties of intracisternal A particles occurring in mouse tumors (complement fixation-immunodiffusion-neuroblastoma-plasma-cell tumor).

Authors:  E L Kuff; K K Leuders; H L Ozer; N A Wivel
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  11 in total

1.  Two-dimensional gel analysis of complex DNA families: methodology and apparatus.

Authors:  R D Sheppard; X Montagutelli; W C Jean; J Y Tsai; A Rose; J L Guénet; M D Cole; L M Silver
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

2.  Complete nucleotide sequence of a mouse VL30 retro-element.

Authors:  S E Adams; P D Rathjen; C A Stanway; S M Fulton; M H Malim; W Wilson; J Ogden; L King; S M Kingsman; A J Kingsman
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

3.  Isolation and characterization of a family of rat endogenous retroviral sequences.

Authors:  M Nakamuta; M Furuich; K Takahashi; N Suzuki; H Endo; M Yamamoto
Journal:  Virus Genes       Date:  1989-09       Impact factor: 2.332

4.  An internal ribosomal entry signal in the rat VL30 region of the Harvey murine sarcoma virus leader and its use in dicistronic retroviral vectors.

Authors:  C Berlioz; C Torrent; J L Darlix
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

5.  Independent regulation of mouse VL30 retrotransposon expression in response to serum and oncogenic cell transformation.

Authors:  L Eaton; J D Norton
Journal:  Nucleic Acids Res       Date:  1990-04-25       Impact factor: 16.971

6.  Harvey sarcoma virus genome contains no extensive sequences unrelated to those of other retroviruses except ras.

Authors:  K F Manly; G R Anderson; D L Stoler
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

7.  Transient expression of a chloramphenicol acetyltransferase gene following transfection of Physarum polycephalum myxamoebae.

Authors:  K McCurrach; L A Glover; N Hardman
Journal:  Curr Genet       Date:  1988       Impact factor: 3.886

8.  Sequence analysis of Mus dunni endogenous virus reveals a hybrid VL30/gibbon ape leukemia virus-like structure and a distinct envelope.

Authors:  G Wolgamot; L Bonham; A D Miller
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

9.  Inducible and cell type-specific expression of VL30 U3 subgroups correlate with their enhancer design.

Authors:  M Nilsson; S Bohm
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

10.  Anoxia-inducible rat VL30 elements and their relationship to ras-containing sarcoma viruses.

Authors:  B A Firulli; G R Anderson; D L Stoler; S D Estes
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.